SuperworthBeyondSpring market cap BYSI
Share price times shares outstanding: what the whole company sells for, since 2017.
- Today, Oct 23, 2026
- $17.7M
- Highest close in our data
- $1.1B
- Aug 2021
BeyondSpring is worth $17.7M at the close on Oct 23, 2026, at $0.43 a share.
That is down 78% over the last year and down 97% over five years.
Its highest close in our data was $1.1B in Aug 2021.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $17.7M | $17.7M | $76.9M | −76% |
| 2025 | $74.2M | $44.3M | $127.8M | +17% |
| 2024 | $63.2M | $34.3M | $139.2M | +80% |
| 2023 | $35.1M | $28.8M | $105.1M | −52% |
| 2022 | $73.2M | $22.3M | $177.3M | −59% |
| 2021 | $177.3M | $157.4M | $1.1B | −48% |
| 2020 | $340.2M | $240.4M | $502.2M | −8% |
| 2019 | $367.9M | $284.7M | $549.5M | −17% |
| 2018 | $441.8M | $362.9M | $700.7M | −10% |
| 2017 | $490.9M | $415.9M | $734.3M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest BeyondSpring's size, closest first, today.
| Company | Market cap |
|---|---|
| BYSIBeyondSpring | $17.7M |
| ATNMActinium Pharmaceuticals | $47.8M |
| SPROSpero Therapeutics | $64.6M |
| LFVNLifevantage | $73.4M |
| Peer median | $64.6M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on BeyondSpring
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.